The United States Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 5,691.12 million in 2022, USD 6,125.68 million in 2023 and is projected to grow at a CAGR of 7.73% to reach USD 10,328.24 million by 2030.
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Clinical Trial Supply & Logistics for Pharmaceutical Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
4. What is the competitive strategic window for opportunities in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
5. What are the technology trends and regulatory frameworks in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
6. What is the market share of the leading vendors in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
7. What modes and strategic moves are considered suitable for entering the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
Cumulative Impact of COVID-19:
COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Clinical Trial Supply & Logistics for Pharmaceutical Market.Cumulative Impact of Russia-Ukraine Conflict:
The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Clinical Trial Supply & Logistics for Pharmaceutical Market considering the current update on the conflict and its global responses.Cumulative Impact of High Inflation:
The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Clinical Trial Supply & Logistics for Pharmaceutical Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.Market Segmentation & Coverage:
The report on the United States Clinical Trial Supply & Logistics for Pharmaceutical Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Clinical Trial Supply & Logistics for Pharmaceutical Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:- Based on Phase, the market is studied across BA/BE Studies, Phase I, Phase II, Phase III, and Phase IV.
- Based on Sector, the market is studied across Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, and Clinical Trial Supply Chain Management.
- Based on Therapeutic Area, the market is studied across Blood Disorders, Digestive System Diseases, Infectious and Immune System Diseases, Neurological and Mental Disorders, and Oncology.
- Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Clinical Trial Supply & Logistics for Pharmaceutical Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Clinical Trial Supply & Logistics for Pharmaceutical Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Clinical Trial Supply & Logistics for Pharmaceutical Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market, including Almac Group, AmerisourceBergen Corporation, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, ICON PLC, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Metrics Contract Services by Mayne Pharma group, Movianto, N-Side, Parexel International Corporation, PCI Pharma Services, Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., and UDG Healthcare PLC.The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?2. What are the inhibiting factors and impact of COVID-19 shaping the United States Clinical Trial Supply & Logistics for Pharmaceutical Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
4. What is the competitive strategic window for opportunities in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
5. What are the technology trends and regulatory frameworks in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
6. What is the market share of the leading vendors in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
7. What modes and strategic moves are considered suitable for entering the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
Frequently Asked Questions about the U.S. Clinical Trial Supply & Logistics for Pharmaceutical Market
What is the estimated value of the U.S. Clinical Trial Supply & Logistics for Pharmaceutical Market?
What is the growth rate of the U.S. Clinical Trial Supply & Logistics for Pharmaceutical Market?
What is the forecasted size of the U.S. Clinical Trial Supply & Logistics for Pharmaceutical Market?
Who are the key companies in the U.S. Clinical Trial Supply & Logistics for Pharmaceutical Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | January 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 5691.12 Million |
| Forecasted Market Value ( USD | $ 10328.24 Million |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | United States |
| No. of Companies Mentioned | 23 |
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization
6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
6.1. Introduction
6.2. BA/BE Studies
6.3. Phase I
6.4. Phase II
6.5. Phase III
6.6. Phase IV
7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector
7.1. Introduction
7.2. Clinical Trial Logistics and Distributions
7.3. Clinical Trial Manufacturing Services
7.4. Clinical Trial Supply Chain Management
8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area
8.1. Introduction
8.2. Blood Disorders
8.3. Digestive System Diseases
8.4. Infectious and Immune System Diseases
8.5. Neurological and Mental Disorders
8.6. Oncology
9. California Clinical Trial Supply & Logistics for Pharmaceutical Market
9.1. Introduction
10. Florida Clinical Trial Supply & Logistics for Pharmaceutical Market
10.1. Introduction
11. Illinois Clinical Trial Supply & Logistics for Pharmaceutical Market
11.1. Introduction
12. New York Clinical Trial Supply & Logistics for Pharmaceutical Market
12.1. Introduction
13. Ohio Clinical Trial Supply & Logistics for Pharmaceutical Market
13.1. Introduction
14. Pennsylvania Clinical Trial Supply & Logistics for Pharmaceutical Market
14.1. Introduction
15. Texas Clinical Trial Supply & Logistics for Pharmaceutical Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Almac Group
17.2. AmerisourceBergen Corporation
17.3. Bilcare Limited
17.4. Biocair International Limited
17.5. Catalent, Inc.
17.6. Clinigen Group PLC
17.7. DHL International GmbH by Deutsche Post AG
17.8. Eurofins Scientific SE
17.9. FedEx Corporation
17.10. ICON PLC
17.11. Infosys Limited
17.12. KLIFO A/S
17.13. Lonza Group
17.14. Marken
17.15. Metrics Contract Services by Mayne Pharma group
17.16. Movianto
17.17. N-Side
17.18. Parexel International Corporation
17.19. PCI Pharma Services
17.20. Seveillar Clinical Trial Supplies Pvt. Ltd.
17.21. SIRO Clinpharm Private Limited
17.22. Thermo Fisher Scientific, Inc.
17.23. UDG Healthcare PLC
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET DYNAMICS
FIGURE 8. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY PHASE, 2030
FIGURE 12. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY SECTOR, 2030
FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
FIGURE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTIC AREA, 2030
FIGURE 26. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
FIGURE 31. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 39. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 40. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY STATE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 35. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 36. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 37. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 38. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 39. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 40. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 41. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 42. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 43. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 44. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 45. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 46. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 47. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 48. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 49. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 50. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 51. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 52. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 53. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 54. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 55. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 56. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 57. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 58. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 60. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2030 (USD MILLION)
TABLE 61. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 63. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 64. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 65. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET RANKING, BY KEY PLAYER, 2022
TABLE 66. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2022
TABLE 67. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 68. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET MERGER & ACQUISITION
TABLE 69. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 70. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 71. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET INVESTMENT & FUNDING
TABLE 72. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 73. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: LICENSE & PRICING
Companies Mentioned
- Almac Group
- AmerisourceBergen Corporation
- Bilcare Limited
- Biocair International Limited
- Catalent, Inc.
- Clinigen Group PLC
- DHL International GmbH by Deutsche Post AG
- Eurofins Scientific SE
- FedEx Corporation
- ICON PLC
- Infosys Limited
- KLIFO A/S
- Lonza Group
- Marken
- Metrics Contract Services by Mayne Pharma group
- Movianto
- N-Side
- Parexel International Corporation
- PCI Pharma Services
- Seveillar Clinical Trial Supplies Pvt. Ltd.
- SIRO Clinpharm Private Limited
- Thermo Fisher Scientific, Inc.
- UDG Healthcare PLC
Methodology
LOADING...
